Induced Pluripotent Stem Cells Production Market (By Process: Manual, Automated; By Product: Instruments/Devices, Automated Platforms, Consumables & Kits, Services; By Workflow: Reprogramming, Cell Culture, Cell, Engineering, Others; By Application: Drug Development and Discovery, Regenerative Medicine, Toxicology Studies, Others; By End-use: Research & Academic Institute, Hospitals & clinics) - Global Industry Analysis, Size, Share, Growth, Trends, Revenue, Regional Outlook 2021 – 2030

Published Date : Oct 2021 | No. of Pages : 150+ Pages | Category : Healthcare

The global induced pluripotent stem cells production market size is expected to be worth around US$ 2.70 billion by 2030, according to a new report by Vision Research Reports.

The global induced pluripotent stem cells production market size was valued at US$ 950.29 million in 2020 and is anticipated to grow at a CAGR of 9.0% during forecast period 2021 to 2030.

Induced Pluripotent Stem Cells Production Market Size 2021 to 2030

Report Coverage

Report Scope Details
Market Size USD 2.70 billion by 2030
Growth Rate CAGR of 9.0% From 2021 to 2030
Base Year 2021
Historic Data 2017 to 2020
Forecast Period 2021 to 2030
Segments Covered Process, Product, Workflow, Application, End-use
Regional Scope North America, Europe, Asia Pacific, Latin America, Middle East & Africa
Companies Mentioned Lonza; Axol Biosciences Ltd.; Evotec; Hitachi Ltd.; Merck KGaA; REPROCELL Inc.; Fate Therapeutics; Thermo Fisher Scientific, Inc.; StemCellFactory III; Applied StemCell Inc.

Growth Factors

 The market is driven by technological advancements in induced pluripotent cell manufacturing, rising awareness about the therapeutic potency of such cells, and extensive research on the development of  using induced pluripotent cells. The ability of iPS cells to differentiate with maximum diversity has been one of the key drivers propelling its usage in gene and cell therapy applications. The high therapeutic potential of induced pluripotent stem cells (iPSCs) has expanded its applications in the past few years making significant contributions to the market revenue.

The robust pipeline for iPSC-derived cell therapeutics coupled with emerging applications of iPSCs is anticipated to accelerate the market growth. As of 2021, the total number of iPSC clinical trials has risen to 54. For instance, Allele Biotechnology & Pharmaceuticals is developing a diabetics drug from iPSC-derived pancreatic beta cells.

Report Highlights

The manual iPSC production process segment dominated the global market in 2020 with a revenue share of 80.13%. The iPSC production process can be cost-effective and efficient by simply optimizing the manual steps routinely used to reprogram patient cells.  

The automated iPSC production process is expected to register the fastest CAGR from 2021 to 2030. Increasing demand for reproducible large-scale stem cell and differentiated progeny production, with minimum variation, propels the demand for automation platforms. 

Several of these initiatives plan to use automated systems to achieve their goal. For instance, various consortiums in Europe aim to develop iPSCs biobank for different diseases.

Cell culture was the dominant workflow segment in 2020 with a revenue share of more than 40% and is estimated to expand further at a steady CAGR over the forecast period. The studies of stem cell behavior and differentiation in development are complicated, expensive, and time-consuming, and thus, cell culture is a prominent workflow in generating iPSC. Traditional human-induced pluripotent stem cells culture technique requires the use of human or mouse fibroblast feeder layers, which is a time-consuming and labor-intensive process.

the reprogramming of iPSCs production market space has undergone various advancements in the past few years. The reprogramming of somatic cells into iPS cells has a high potential, enabling researchers to push forward groundbreaking research and discover the advanced generation of therapeutics.

the differentiation type is also expected to show significant growth in the coming years. Several companies are dedicated to providing different viable and cost-effective methods for iPSCs differentiation, which supports segment growth

The automated platforms segment is expected to register the fastest CAGR of 9.9% from 2021 to 2030. Automated platforms are known to produce more reliable iPSCs, minimizing human bias, while ensuring standardization of protocols.

The Instruments/devices accounted for the second-highest revenue share in 2020. The instruments/devices have the potential to help in iPSC generation by regulating the kinetics of reprogramming factor delivery. A substantial number of players are offering instruments/devices under this segment.

The drug development & discovery segment accounted for the largest revenue share of 45.90% of the global induced pluripotent stem cells generation market in 2020. iPSCs have broad applications in efficacy and safety evaluation during the drug development process. 

iPSCs allow in vitro differentiation into various types of cells that constitute the organs and tissues. Currently, commercially usable iPSC-derived products include hepatocytes, cardiomyocytes, islet cells, vascular endothelial cells, and neurons, which are being studied to explain the mechanisms of human-specific adverse events and toxicity screening during drug exploration.

The regenerative medicine segment is expected to witness the fastest CAGR over the forecast period owing to the ability of iPSCs to propagate indefinitely. In addition, the development and launch of new platforms are contributing to the segment growth.

Biotechnology & pharmaceutical companies dominated the market with a revenue share of more than 60% in 2020. Acknowledging the profitable opportunities posed by the market, biotechnology companies are focused on initiating new product development to strengthen their market presence.

researchers have taken iPSCs from the lab to the clinics. iPSCs have been utilized in many clinical and research studies, including regenerative medicine, disease modeling, and drug toxicity/drug discovery studies. The utilization of iPSCs in regenerative medicine gives a great opportunity for the clinical translation of this technology.

North America dominated the market with a revenue share of more than 53% in 2020 The robust business model in the U.S. and Canada contributed to the market growth in the region. Moreover, organizations are investing in research programs related to iPSCs.

Europe is expected to witness steady growth over the forecast period. The development of the EBiSC accelerates the research activities about iPSCs in this region. The EBiSC aims to deliver disease-relevant, quality-controlled, research-grade iPS cell lines, data, and cell services. 

Companies are entering into agreements for expanding their iPSC-derived therapies, which, in turn, will drive the research activities in the region. In June 2021, Neurophth Therapeutics formed a strategic partnership with Hopstem Biotechnology to develop human iPSC-derived therapies for the treatment of ocular diseases. Under

Key Players

  • Lonza

  • Axol Biosciences Ltd.

  • Evotec

  • Hitachi Ltd.

  • Merck KGaA

  • REPROCELL, Inc.

  • Fate Therapeutics

  • Thermo Fisher Scientific, Inc.

  • StemCellFactory III

  • Applied StemCell, Inc. 

Market Segmentation

  • Process

    • Manual

    • Automated

  • Product 

    • Instruments/Devices

    • Automated Platforms

    • Consumables & Kits

      • Media

      • Kits

      • Others

    • Services

  • Workflow 

    • Reprogramming

    • Cell Culture

    • Cell Characterization/Analysis

    • Engineering

    • Others

  • Application 

    • Drug Development and Discovery

    • Regenerative Medicine

    • Toxicology Studies

    • Others

  • End-use 

    • Research & Academic Institutes

    • Biotechnology & Pharmaceutical Companies

    • Hospitals & clinics

  • Regional 

    • North America

      • U.S.

      • Canada

    • Europe

      • Germany

      • U.K.

      • France

      • Italy

    • Asia Pacific

      • Japan

      • China

      • India

    • Latin America

      • Brazil

      • Mexico

    • Middle East & Africa

      • South Africa

      • Saudi Arabia

The Induced Pluripotent Stem Cells Production market research report covers definition, classification, product classification, product application, development trend, product technology, competitive landscape, industrial chain structure, industry overview, national policy and planning analysis of the industry, the latest dynamic analysis, etc., and also includes major. The study includes drivers and restraints of the global market. It covers the impact of these drivers and restraints on the demand during the forecast period. The report also highlights opportunities in the market at the global level.

The report provides size (in terms of volume and value) of Induced Pluripotent Stem Cells Production market for the base year 2020 and the forecast between 2021 and 2030. Market numbers have been estimated based on form and application. Market size and forecast for each application segment have been provided for the global and regional market.

This report focuses on the global Induced Pluripotent Stem Cells Production market status, future forecast, growth opportunity, key market and key players. The study objectives are to present the Induced Pluripotent Stem Cells Production market development in United States, Europe and China.

It is pertinent to consider that in a volatile global economy, we haven’t just conducted Induced Pluripotent Stem Cells Production market forecasts in terms of CAGR, but also studied the market based on key parameters, including Year-on-Year (Y-o-Y) growth, to comprehend the certainty of the market and to find and present the lucrative opportunities in market.

In terms of production side, this report researches the Induced Pluripotent Stem Cells Production capacity, production, value, ex-factory price, growth rate, market share for major manufacturers, regions (or countries) and type.

In terms of consumption side, this report focuses on the consumption of Induced Pluripotent Stem Cells Production by regions (countries) and application.

Buyers of the report will have access to verified market figures, including global market size in terms of revenue and volume. As part of production analysis, the authors of the report have provided reliable estimations and calculations for global revenue and volume by Type segment of the global Induced Pluripotent Stem Cells Production market. These figures have been provided in terms of both revenue and volume for the period 2017 to 2030. Additionally, the report provides accurate figures for production by region in terms of revenue as well as volume for the same period. The report also includes production capacity statistics for the same period.

With regard to production bases and technologies, the research in this report covers the production time, base distribution, technical parameters, research and development trends, technology sources, and sources of raw materials of major Induced Pluripotent Stem Cells Production market companies.

Regarding the analysis of the industry chain, the research of this report covers the raw materials and equipment of Induced Pluripotent Stem Cells Production market upstream, downstream customers, marketing channels, industry development trends and investment strategy recommendations. The more specific analysis also includes the main application areas of market and consumption, major regions and Consumption, major Chinese producers, distributors, raw material suppliers, equipment providers and their contact information, industry chain relationship analysis.

The research in this report also includes product parameters, production process, cost structure, and data information classified by region, technology and application. Finally, the paper model new project SWOT analysis and investment feasibility study of the case model.

Overall, this is an in-depth research report specifically for the Induced Pluripotent Stem Cells Production industry. The research center uses an objective and fair way to conduct an in-depth analysis of the development trend of the industry, providing support and evidence for customer competition analysis, development planning, and investment decision-making. In the course of operation, the project has received support and assistance from technicians and marketing personnel in various links of the industry chain.

Induced Pluripotent Stem Cells Production market competitive landscape provides details by competitor. Details included are company overview, company financials, revenue generated, market potential, investment in research and development, new market initiatives, global presence, production sites and facilities, production capacities, company strengths and weaknesses, product launch, product width and breadth, application dominance. The above data points provided are only related to the companies’ focus related to Induced Pluripotent Stem Cells Production market.

Prominent players in the market are predicted to face tough competition from the new entrants. However, some of the key players are targeting to acquire the startup companies in order to maintain their dominance in the global market. For a detailed analysis of key companies, their strengths, weaknesses, threats, and opportunities are measured in the report by using industry-standard tools such as the SWOT analysis. Regional coverage of key companies is covered in the report to measure their dominance. Key manufacturers of Induced Pluripotent Stem Cells Production market are focusing on introducing new products to meet the needs of the patrons. The feasibility of new products is also measured by using industry-standard tools.

Key companies are increasing their investments in research and development activities for the discovery of new products. There has also been a rise in the government funding for the introduction of new Induced Pluripotent Stem Cells Production market. These factors have benefited the growth of the global market for Induced Pluripotent Stem Cells Production. Going forward, key companies are predicted to benefit from the new product launches and the adoption of technological advancements. Technical advancements have benefited many industries and the global industry is not an exception.

New product launches and the expansion of already existing business are predicted to benefit the key players in maintaining their dominance in the global market for Induced Pluripotent Stem Cells Production. The global market is segmented on the basis of region, application, en-users and product type. Based on region, the market is divided into North America, Europe, Asia-Pacific, Latin America and Middle East and Africa (MEA).

In this study, the years considered to estimate the market size of Induced Pluripotent Stem Cells Production are as follows:

  • History Year: 2017-2020
  • Base Year: 2021
  • Forecast Year 2021 to 2030

Reasons to Purchase this Report:


- Market segmentation analysis including qualitative and quantitative research incorporating the impact of economic and policy aspects
- Regional and country level analysis integrating the demand and supply forces that are influencing the growth of the market.
- Market value USD Million and volume Units Million data for each segment and sub-segment
- Competitive landscape involving the market share of major players, along with the new projects and strategies adopted by players in the past five years
- Comprehensive company profiles covering the product offerings, key financial information, recent developments, SWOT analysis, and strategies employed by the major market players

Research Methodology:

In-depth interviews and discussions were conducted with several key market participants and opinion leaders to compile the research report.

This research study involved the extensive usage of both primary and secondary data sources. The research process involved the study of various factors affecting the industry, including the government policy, market environment, competitive landscape, historical data, present trends in the market, technological innovation, upcoming technologies and the technical progress in related industry, and market risks, opportunities, market barriers and challenges. The following illustrative figure shows the market research methodology applied in this report.

Market Size Estimation

Top-down and bottom-up approaches are used to estimate and validate the global market size for company, regional division, product type and application (end users).

The market estimations in this report are based on the selling price (excluding any discounts provided by the manufacturer, distributor, wholesaler or traders). Market share analysis, assigned to each of the segments and regions are achieved through product utilization rate and average selling price.

Major manufacturers & their revenues, percentage splits, market shares, growth rates and breakdowns of the product markets are determined through secondary sources and verified through the primary sources.

All possible factors that influence the markets included in this research study have been accounted for, viewed in extensive detail, verified through primary research, and analyzed to get the final quantitative and qualitative data. The market size for top-level markets and sub-segments is normalized, and the effect of inflation, economic downturns, and regulatory & policy changes or others factors are accounted for in the market forecast. This data is combined and added with detailed inputs and analysis from Vision Research Reports and presented in this report.

Market Breakdown and Data Triangulation

After complete market engineering with calculations for market statistics; market size estimations; market forecasting; market breakdown; and data triangulation. Extensive primary research was conducted to gather information and verify and validate the critical numbers arrived at. In the complete market engineering process, both top-down and bottom-up approaches were extensively used, along with several data triangulation methods, to perform market estimation and market forecasting for the overall market segments and sub-segments listed in this report.

Secondary Sources

Secondary Sources occupies approximately 25% of data sources, such as press releases, annual reports, Non-Profit organizations, industry associations, governmental agencies and customs data, and so on. This research study includes secondary sources; directories; databases such as Bloomberg Business, Wind Info, Hoovers, Factiva (Dow Jones & Company), TRADING ECONOMICS, and avention; Investing News Network; statista; Federal Reserve Economic Data; annual reports; investor presentations; and SEC filings of companies.

Primary Sources

In the primary research process, various sources from both the supply and demand sides were interviewed to obtain qualitative and quantitative information for this report. The primary sources from the supply side include product manufacturers (and their competitors), opinion leaders, industry experts, research institutions, distributors, dealer and traders, as well as the raw materials suppliers and producers, etc.

The primary sources from the demand side include industry experts such as business leaders, marketing and sales directors, technology and innovation directors, supply chain executive, end users (product buyers), and related key executives from various key companies and organizations operating in the global market.

The study objectives of this report are:

  • To analyze and study the global market capacity, production, value, consumption, status (2017-2020) and forecast (2021-2030);
  • Focuses on the key manufacturers, to study the capacity, production, value, market share and development plans in future.
  • Comprehensive company profiles covering the product offerings, key financial information, recent developments, SWOT analysis, and strategies employed by the major market players
  • To define, describe and forecast the market by type, application and region.
  • To analyze the global and key regions market potential and advantage, opportunity and challenge, restraints and risks.
  • To identify significant trends and factors driving or inhibiting the market growth.
  • To analyze the opportunities in the market for stakeholders by identifying the high growth segments.
  • To strategically analyze each submarket with respect to individual growth trend and their contribution to the market
  • To analyze competitive developments such as expansions, agreements, new product launches, and acquisitions in the market
  • To strategically profile the key players and comprehensively analyze their growth strategies.

Featured Research Reports

  • Featured Research Reports

    Healthcare ERP Market (By Function: Inventory and Material Management, Supply Chain and Logistics Management, Patient Relationship Management, Finance and Billing; By Deployment: On-premises, Cloud) - Global Industry Analysis, Size, Share, Growth, Trends, Revenue, Regional Outlook 2021 – 2030

    Read more...
  • Featured Research Reports

    Biotechnology & Pharmaceutical Services Outsourcing Market (By Service: Consulting, Auditing and Assessment, Regulatory Affairs, Product Maintenance, Product Design & Development, Product Testing & Validation, Training & Education; By End-use: Pharma, Biotech) - Global Industry Analysis, Size, Share, Growth, Trends, Revenue, Regional Outlook 2021 – 2030

    Read more...
  • Featured Research Reports

    Endoscopy Operative Devices Market (By Product: Energy Systems, Access Devices, Suction & Irrigation Systems, Hand Instruments, Wound Retractors, Snares; By Application: Gastrointestinal (GI) Endoscopy, Laparoscopy, Obstetrics/ Gynecology Endoscopy, Arthroscopy, Urology Endoscopy (Cystoscopy), Bronchoscopy, Mediastinoscopy, Otoscopy, Laryngoscopy) - Global Industry Analysis, Size, Share, Growth, Trends, Revenue, Regional Outlook 2021 – 2030

    Read more...
  • Featured Research Reports

    Weight Loss Supplements Market (By Type: Liquid, Powder, Softgels, Pills; By Ingredient: Vitamins & Minerals, Amino Acids, Natural Extracts/ Botanicals; By End-user: Under 18 years, 18 to 40 years, 40 to 50 years, Above 50 years; By Distribution Channel: Offline Channel, Online Channel) - Global Industry Analysis, Size, Share, Growth, Trends, Revenue, Regional Outlook 2021 – 2030

    Read more...
  • Featured Research Reports

    Healthcare ERP Consulting Services Market (By Functionality: Implementation, Training & Education; By End-Use: Life Science Companies, Healthcare Providers) - Global Industry Analysis, Size, Share, Growth, Trends, Revenue, Regional Outlook 2021 – 2030

    Read more...